secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001193125-24-016143
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus confirms patent infringement lawsuit by Novartis over generic Lutetium Lu 177 Dotatate ANDA
--------------------------------------------------------------------------------

- Lawsuit filed by Advanced Accelerator Applications (Novartis entities) in U.S. District Court for Delaware against Lantheus and its subsidiary.
- Suit stems from Lantheus's ANDA No. 217060 for generic version of LUTATHERA (lutetium Lu 177 dotatate) for GEP-NETs.
- Lantheus believes it is the 'first applicant' and eligible for 180 days of generic marketing exclusivity in the U.S.
- No financial impact or settlement terms disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312524016143/0001193125-24-016143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312524016143/d740568d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-016143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer